Clinical Evaluation of an Individualized Risk Prediction Tool for Men on Active Surveillance for Prostate Cancer

Joseph H. Huntley, Rebecca Y. Coley, H Ballentine Carter, Archana Radhakrishnan, Melinda Krakow, Craig Pollack

Research output: Contribution to journalArticle

Abstract

Objective: To determine whether providing individualized predictions of health outcomes to men on active surveillance (AS) alleviates cancer-related anxiety and improves risk understanding. Materials and Methods: We consecutively recruited men from our large, institutional AS program before (n = 36) and after (n = 31) implementation of a risk prediction tool. Men in both groups were surveyed before and after their regular visits to assess their perceived cancer control, biopsy-specific anxiety, and burden from cancer-related information. We compared pre-/post-visit differences between men who were and were not shown the tool using two-sample t-tests. Satisfaction with and understanding of the predictions were elicited from men in the intervention period. Results: Men reported a relatively high level of cancer control at baseline. Men who were not shown the tool saw a 6.3 point increase (scaled from 0 to 100) in their perceived cancer control from before to after their visit whereas men who were shown the tool saw a 12.8 point increase, indicating a statistically significant difference between groups (p =.04). Biopsy-specific anxiety and burden from cancer information were not significantly different between groups. Men were satisfied with the tool and demonstrated moderate understanding. Conclusion: Providing individualized predictions to men on AS helps them better understand their cancer risk and should be considered at other clinical sites.

Original languageEnglish (US)
Pages (from-to)118-124
Number of pages7
JournalUrology
Volume121
DOIs
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Clinical Evaluation of an Individualized Risk Prediction Tool for Men on Active Surveillance for Prostate Cancer'. Together they form a unique fingerprint.

  • Cite this